
|Videos|October 31, 2015
How the FDA Views Compounding
Ronna B. Hauser, PharmD, vice president of pharmacy affairs for the National Community Pharmacists Association (NCPA), talks about the current position of the FDA regarding compounding.
Advertisement
Ronna B. Hauser, PharmD, vice president of pharmacy affairs for the National Community Pharmacists Association (NCPA), talks about the current position of the FDA regarding compounding.
This video was recorded at the 2015 NCPA Annual Convention.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Fall 2025 Quiz: Test Your Pharmacy Knowledge!
2
Earlier Menopause, Reduced Cardiac Function Potentially Linked With Negative Impacts on Brain Health
3
FDA Approves Elinzanetant as First Nonhormonal Therapy for Menopause Vasomotor Symptoms
4
Menopause Care Varies by Provider, Highlighting Need for Standardized Education
5













































































































































































































